What We Do
Rx Bandz has developed MiniJect™ an innovative, next generation auto-injector that provides a simple solution for the challenges patients face.
Rx Bandz has earned a distinct advantage in these growing sectors. It is the only wearable device designed to safely and effectively meet the delivery needs of a wide range of injectable medications and patients. Our next generation innovative design offers our future biopharmaceutical partners a competitive differentiation to attract customers and gain an edge in the market.
The environment of the U.S. pharmaceutical marketplace is very competitive. Companies spend millions in research, development and licensing agreements to stay relevant and maintain their customers. It is imperative to their growth and success that they offer the most technologically current products to meet their consumer demands. Rx Bandz auto-injectors offer innovative, patient-centric design in a next generation solution providing our partners a competitive edge.
The overall injectable market continues to grow as there is an increased incidence of severe allergies and continued unmet patients needs.
Rx Bandz provides a better solution for a huge growth segment in the pharmaceutical industry that has been triggered by a wave of patient frustration.
For drug auto injectable devices, patient centric engineering and user ergonomics are essential attributes that impact critical patient issues such as safety, efficacy and ease of administration. Our engineers and design team have reinvented the standardized auto- injectable drug platform – creating a patient-friendly device while maintaining the safety and efficacy of the drug delivery.
Rx Bandz provides an opportunity for investors and strategic partners to be a part of an innovative life saving solution in the high growth self injectable market.
Rx Bandz unique product, strong business model and patient-centric approach will allow the company to capitalize on this exciting trend in healthcare.